BIOMAT Database Logo BIOMAT Database Logo

Serum iron, copper, magnesium and zinc concentration in chronic pulmonary tuberculosis during chemotherapy with capreomycin-ethambutol-rifampicin combinations. 1970

R Elo, and E Uksila

UI MeSH Term Description Entries
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003300 Copper A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. Copper-63,Copper 63
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

R Elo, and E Uksila
Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.
January 1969, Acta tuberculosea et pneumologica Belgica,
R Elo, and E Uksila
Capreomycin, ethambutol and rifampicin in apparently incurable pulmonary tuberculosis.
January 1969, Scandinavian journal of respiratory diseases. Supplementum,
R Elo, and E Uksila
[Ethambutol, capreomycin and rifampicin in lung tuberculosis].
December 1968, Nordisk medicin,
R Elo, and E Uksila
[Chemotherapy of tuberculosis today with special consideration of capreomycin, ethambutol and rifampicin].
December 1968, Praxis der Pneumologie,
R Elo, and E Uksila
Chemotherapy of chronic pulmonary tuberculosis with polyresistant bacteria with reference to ethambutol and capreomycin.
January 1968, Scandinavian journal of respiratory diseases. Supplementum,
R Elo, and E Uksila
[Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
October 1978, Problemy tuberkuleza,
R Elo, and E Uksila
Results of treatment with ethambutol and capreomycin in chronic pulmonary tuberculosis.
January 1970, Polish medical journal,
R Elo, and E Uksila
[Results of treatment with ethambutol and capreomycin in chronic pulmonary tuberculosis].
July 1969, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
R Elo, and E Uksila
[Chemotherapy for tuberculosis (ethambutol, Capreomycin, etc.)].
June 1967, Naika. Internal medicine,
R Elo, and E Uksila
[Treatment of intractable pulmonary tuberculosis: place of capreomycin in therapeutic programs with rifampicin and ethambutol].
June 1970, Revue de tuberculose et de pneumologie,
Copied contents to your clipboard!